James Johnston named to Greyledge Technologies Board of Directors – Yahoo Finance
The seasoned executive will support and further the biotech company’s cell therapeutics growth by facilitating company expansion, capitalization and strategic development.
DENVER, September 06, 2022–(BUSINESS WIRE)–James Johnston, an innovative executive with extensive financial and strategic experience with global organizations, has joined the board of directors of Greyledge Technologies, Inc. ("Greyledge" or "the Company"). He has served as Chief of Corporate Development for Greyledge since last fall. His extensive network of contacts, diverse strategic abilities and extensive experience in investment banking and private equity will continue to facilitate the cell therapeutics company’s growth strategy, while maintaining its commitment to quality standards.
"Mr. Johnston has been an instrumental member of the Greyledge team in his role as Chief of Corporate Development and we are thrilled to appoint him to the board. Jim is a seasoned leader and, as Greyledge continues to accelerate efforts to scale our novel cellular therapeutics platform in domestic and international markets. He will be a vital asset to access additional growth capital and provide comprehensive strategic guidance," said Dr. David Karli, founder and CEO of Greyledge.
Mr. Johnston has spent 22 years advising and investing in companies across a variety of industries. He brings expertise in financing, mergers and acquisitions, strategic execution and board level decision making. Jim was an investment banker at Goldman Sachs from 2000-2008 in Mergers and Acquisitions and Financial Sponsor Coverage. He joined Nexphase Capital Partners (FKA Moelis Capital Partners) in 2008 where he ultimately ran the Industrials Group as a Partner. In 2018, Mr. Johnston left Nexphase and founded Emerald Lake Advisors in order to focus his energy on investing and advising small entrepreneurial companies.
Mr. Johnston serves on the board of directors of the Red Fox Community School and as a board observer of Jame Rollform Products. He received a BS in Commerce with Distinction from the University of Virginia in 1991 and was commissioned as a Naval Officer through the ROTC program. After graduating Nuclear Power School and Prototype he served as a submarine officer and is a qualified Naval Nuclear Engineer. After his separation from the Navy, he received his MBA from Harvard Business School in 2000.
For more information regarding Greyledge and its biologic products and services, please email info@greyledgebiotech.com.
About Greyledge, Inc.
Founded in 2010 in Colorado, Greyledge is an industry-leading biotech company specializing in cell therapeutics produced from a patient’s own blood or bone marrow tissue. Greyledge has developed industry-leading quality control systems to process these biologic therapy products, used in treating common Orthopedic conditions. The Company is dedicated to maximizing product quality, safety, and reliability in a manner compliant with Federal regulations and ethical standards. The Company has refined its scientific technology, and since 2017, has been driven to achieve sustained profitability and scalability.
Forward-Looking Statements
This press release contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "believes," "plans," "anticipates," "projects," "estimates," "expects," "intends," "strategy," "future," "opportunity," "may," "will," "should," "could," "potential," or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005988/en/
Contacts
Greyledge Technologies
D: (970) 236-8670, info@greyledgebiotech.com
Cathie Wood is finding it hard to catch 2020 in a bottle again. The growth investor who became a market icon as the co-founder and CEO of the popular Ark Invest exchange-traded funds (ETFs) has been losing more than winning these days.
We pick three technology stocks that are better buys than NVIDIA (NVDA), given its gloomy near-term prospects amid declining demand for gaming chips, supply-chain issues and restrictions on selling top AI chips to China.
A steady dividend payout with periodic increase is part of Verizon's (VZ) long-term strategy to provide attractive risk-adjusted returns to its stockholders.
Is this the ultimate safe haven?
Great Panther Mining Limited (TSX: GPR) (NYSE-A: GPL) ("Great Panther" or the "Company"), reports a corporate update following the announcement on September 6, 2022, regarding the filing of a notice of intention to seek creditor protection (the "NOI").
“I still think it’s going to get worse,” Mobius said. “No, we have not hit bottom yet,” Burry wrote.
Unfortunately for some shareholders, the Star Bulk Carriers Corp. ( NASDAQ:SBLK ) share price has dived 25% in the last…
Yahoo Finance anchors discuss an analyst rating on Tesla stock.
Advanced Micro Devices (AMD) closed at $78.72 in the latest trading session, marking a -1.89% move from the prior day.
Yahoo Finance Live anchors discuss quarterly earnings for UiPath and Coupa.
Vladimir Putin, having assembled thousands of soldiers on Ukraine’s eastern borders, gave the order for them to advance west, triggering the most destructive European landwar of this century. On the same day, February 22, in Lower Saxony triumphant Volkswagen executives announced a float of Porsche on the Frankfurt stock market, to a world that no longer cared about the fate of a sports car brand.
With Apple set to release a new generation of sleek products – including the iPhone 14, new smartwatches and updated AirPods – investors are excited about the pop the AAPL stock might see amid the fanfare. A perennial tech juggernaut … Continue reading → The post If You Invested $1,000 in Apple 5 Years Ago, What Would It Be Worth Now? appeared first on SmartAsset Blog.
The chip sector has been getting destroyed … and for good reason. The U.S., putting the clamps down on who can sell what equipment to what country, is seriously hurting companies' revenue. Inventories of chips have gone from nowhere to be found to a glut.
Tech conglomerate International Business Machines (NYSE: IBM), or Big Blue, is one of technology's oldest companies. The business was founded in the early 1900s and has been there through the invention of the computer to the hardware and software solutions it sells today. It's when a company must choose between an already successful incumbent technology or embrace a potentially disruptive one.
Sounding a note of musical irony, Van Morrison sang, “My Mama told me there’d be days like this.” And in an distinctly unironic note, top analysts may start saying the same thing. With rising inflation, rising interest rates, and a falling stock market, we’re in for more volatile days like this. Looking at the big picture from JPMorgan, Dubravko Lakos-Bujas, the firm’s global head of equity macro research, notes the energy crisis – the natural gas shortages in Europe, the high price of oil world
U.S. stocks charged forward Wednesday as Wall Street clawed back from a three-week long sell-off across equity markets.
Not long ago, the key to success in the market was growth – but in today’s environment, with inflation running at a 40+ year high level and the Federal Reserve aggressively hiking interest rates in an effort to push back, growth stocks have taken a beating. According to data from investment bank Goldman Sachs, defining high-growth companies as those forecasting 30% or better expected sales gains, these stocks have contracted by 58% so far this year. But at least one Goldman analyst still sees a
Right now, there are at least two ultra-high-yield dividend stocks that could double your principal by the end of 2028. AGNC Investment (NASDAQ: AGNC) and Annaly Capital Management (NYSE: NLY) currently offer investors dividend yields of 12.2% and 13.8%, respectively. Are these stocks worth the risk?
In this article, we discuss Jeremy Grantham’s warning and his 10 favorite stocks. If you want to see more stocks in this selection, click Jeremy Grantham’s 5 Favorite Stocks. Jeremy Grantham is a famed British investor who co-founded GMO Asset Management and serves as its chief investment strategist. Grantham is known for predicting market bubbles, […]
Berkshire Hathaway's quarterly 13F filing won't give you the full picture regarding Buffett's $5.9 billion hidden portfolio.